2ydo: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 13: | Line 13: | ||
<!-- | <!-- | ||
The line below this paragraph, {{ | The line below this paragraph, {{ABSTRACT_PUBMED_21593763}}, adds the Publication Abstract to the page | ||
(as it appears on PubMed at http://www.pubmed.gov), where | (as it appears on PubMed at http://www.pubmed.gov), where 21593763 is the PubMed ID number. | ||
--> | --> | ||
{{ | {{ABSTRACT_PUBMED_21593763}} | ||
==About this Structure== | ==About this Structure== | ||
| Line 22: | Line 22: | ||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID:021501622</ref><references group="xtra"/> | <ref group="xtra">PMID:021593763</ref><ref group="xtra">PMID:021501622</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Bennett, K.]] | [[Category: Bennett, K.]] | ||
| Line 31: | Line 31: | ||
[[Category: Tate, C G.]] | [[Category: Tate, C G.]] | ||
[[Category: Warne, T.]] | [[Category: Warne, T.]] | ||
[[Category: 7tm receptor]] | |||
[[Category: Agonist bound form]] | |||
[[Category: G protein coupled receptor]] | |||
[[Category: Gpcr]] | |||
[[Category: Receptor]] | |||
[[Category: Seven-helix receptor]] | |||
[[Category: Thermostabilising point mutation]] | |||
Revision as of 15:56, 22 June 2011
THERMOSTABILISED HUMAN A2A RECEPTOR WITH ADENOSINE BOUND
Template:ABSTRACT PUBMED 21593763
About this Structure
2ydo is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Lebon G, Warne T, Edwards PC, Bennett K, Langmead CJ, Leslie AG, Tate CG. Agonist-bound adenosine A(2A) receptor structures reveal common features of GPCR activation. Nature. 2011 May 18. PMID:21593763 doi:10.1038/nature10136
- Lebon G, Bennett K, Jazayeri A, Tate CG. Thermostabilisation of an Agonist-Bound Conformation of the Human Adenosine A(2A) Receptor. J Mol Biol. 2011 Apr 9. PMID:21501622 doi:10.1016/j.jmb.2011.03.075
